When the head gets hit and the neurosurgeon orders blood: is there evidence? Three articles from the last quarter of Transfusion Medicine Reviews Journal Club.

PowerPoint Presentation not yet available.

 

 

 

When the head gets hit and the neurosurgeon orders blood: is there evidence? Three articles from the last quarter of Transfusion Medicine Reviews Journal Club.

 

 

1.            Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. Allard CB, Scarpelini S, Rhind SG, Baker AJ, Shek PN, Tien H, Fernando M, Tremblay L, Morrison LJ, Pinto R, Rizoli SB. J Trauma. 2009 Nov;67(5):959-67.

2.            Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Downey DM, Monson B, Butler KL, Fortuna GR Jr, Saxe JM, Dolan JP, Markert RJ, McCarthy MC. Am Surg. 2009 Nov;75(11):1100-3.

3.            The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury* Figaji AA, Zwane E, Kogels M, Fieggen AG, Argent AC, Le Roux PD, Peter JC. Pediatr Crit Care Med. 2009 Sep 29. [Epub ahead of print]

4.            Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Rowe JA, Opia DH, Williams TN Current Opinion in Hematology 2009,16:480–487

5.            Endothelial cellADAMTS-13 and VWF: production, release, and VWF string cleavage. Nancy A. Turner NA, Nolasco L, Ruggeri ZM, and Moake JL. Blood. 2009;114:5102-5111

6.            Comparison of registered and published primary outcomes in randomized controlled trials. S Mathieu, I Boutron, D Moher et al. JAMA 302: 977-84, 2009

7.            Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. J van Ramshorst, JJ Bax, SLMA Beeres et al. JAMA 301: 1997-2004, 2009

8.            Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery: a prospective randomized pilot study. M Karlsson, L Ternstrom, M Hyllner et al. Thromb Haemost 102: 147-44, 2009 

9.            Risk factors for RhD immunization despite antenatal and postnatal anti-D prophylaxis JM Koelewijn, M de Haas, TGM Vrijkotte et al. BJOG 116: 1307-14, 2009

10.       The CXCL12-3’A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. K Bogunia-Kubik, A Gieryng, D Dlubek, A Lange Bone Marrow Transplantation 33: 273-78, 2009

11.       Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions and clinical results in refractory CLL. Klepfish A, Gilles L, Ioannis K, et al. Contemporary Challenges in Autoimmunity 2009; 1173: 865-873.

12.       Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience. O’Brien SF, Fan W, Xi G, et al. Vox Sang 2009; September 14 [Epub ahead of print]. and Factors influencing confidential unit exclusions in blood donors. Sümnig A, Konerding U, Kohlmann T, et al. Vox Sang 2009; September 16 [Epub ahead of print].

13.       Hyperkalemia following massive transfusion in trauma. Au BK, Dutton WD, Zaydfudium V, et al. Journal of Surgical Research 2009; 157: 284-289.

14.       Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Stanworth SJ, Clarke P, Watts T, et al. Pediatrics 2009; 124: e826-e834.

15.       Room for (performance) improvement: provider-related factors associated with poor outcomes in massive transfusion. Cotton BA, Dossett LA, Au BK, et al. J Trauma 2009; 67: 1004-1012.